Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here
Cohort begins May 4, 2020
Expeditionary research is about more than just building site capacity. By expanding the reach of your study into remote areas, you provide sustained support to sites with the right patient population that is eager to participate in clinical research. Because most of these sites would not otherwise be able to conduct clinical trial research on top of their everyday duties, that sustained support provides a myriad of benefits.
Expeditionary research gives sites:
Many sites around the world have the equipment and the infrastructure, but little to no opportunity to participate in research because of their location. Expeditionary research gives these sites the same opportunities already available to sites in other parts of the world.
For some patients in remote areas, access to potential treatment options or basic standards of care such as routine checkups can be limited. By expanding your clinical trial to include remote regions and countries, you give patients access to options that were previously unavailable.
Since prospective study indications are not limited to emerging or reemerging infectious diseases, it is possible to research potential treatments for a variety of therapeutic areas. What’s more, because certain conditions and diseases may be present in high density in some areas, your study may bring new options for people to receive better access to health care providers and diagnoses.
Clinical trials are more complex than ever. Helping you to create a healthier world for others depends on real solutions that make the most of tight study budgets and timelines. By taking your clinical trial to remote countries and locations, you gain efficiencies that can help create a better clinical environment to help your study succeed.
From the beginning, your clinical trial may benefit from regulatory environments in some regions that allow for faster study startup and rapid enrollment. Furthermore, your study budget may stretch farther in regions where expenses are less, which makes it cost-effective to conduct clinical trials in these areas.
Another benefit is that study screening and enrollment is streamlined due to the availability of patient populations with a high density of specific therapeutic conditions. And unlike study populations in other parts of the world, patients tend to be treatment naïve which means fewer concomitant medication criteria screen failures.
Since our expeditionary CRO service model is built to work with a variety of therapeutic conditions, you now have more possibilities to bring your study to new populations than ever before.
Our expeditionary CRO service model is uniquely positioned to support your study in remote regions through our scalable delivery ecosystem. We work with an existing regional group of partners in each area which means you not only get the benefit of our 25 years of experience in drug development, but you also have access to a network of established, trusted partners with specific geographic expertise. Our decades of experience conducting expeditionary research means the ecosystem needed to support your study is already in place.
By having self-sufficient environments that can support and sustain clinical research in remote locations, we put your study into secure ecosystems that function at optimal levels no matter the therapeutic area. From logistics to laboratory, to regulatory and everything in between, we have your study covered, making us a one-stop shop for expeditionary research.
Decades of conducting clinical research for the U.S. government in remote regions has fully equipped our expeditionary research model to become the network it is today. It is built to support your clinical trial across any therapeutic area in remote locations around the globe.
In order to execute studies in remote regions, also requires you to have supportive and flexible technology to enable you to capture data and relay it to the cloud.
Your expeditionary research is fully supported by the power of the Medidata Rave® cloud-based clinical trial platform. This means your sites have the technology they need to conduct your study no matter where they’re located. For remote site staff in the field, satellite communication gives them the ability to capture information and collect source documents and upload to the cloud even when they’re offline. Because of this, everyone supporting your study has the tools and the access they need to support your study securely and efficiently.